×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Poultry Vaccines Market

ID: MRFR/Pharma/48783-HCR
200 Pages
Rahul Gotadki
February 2026

India Poultry Vaccines Market Research Report By Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines), By Species (Broilers, Layers, Turkeys, Others), By Administration Route (Intramuscular, Subcutaneous, Oral, Inhalation) and By Disease Targeted (Newcastle Disease, Infectious Bursal Disease, Avian Influenza, Marek's Disease) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Poultry Vaccines Market Infographic
Purchase Options

India Poultry Vaccines Market Summary

As per analysis, the India Poultry Vaccines Market is projected to grow from USD 102.5 Million in 2024 to USD 186.5 Million by 2035, exhibiting a compound annual growth rate (CAGR) of 5.59% during the forecast period (2025 - 2035).

Key Market Trends & Highlights

The India Poultry Vaccines Market is poised for growth driven by technological advancements and increasing awareness of animal health.

  • The Infectious Bronchitis segment remains the largest in the market, reflecting a sustained demand for effective vaccination solutions.
  • Newcastle Disease vaccines are experiencing the fastest growth, indicating a rising focus on combating emerging poultry diseases.
  • Live Attenuated Vaccines dominate the market, while Recombinant Vaccines are rapidly gaining traction due to their innovative approaches.
  • Key market drivers include increasing poultry production and government initiatives aimed at enhancing animal health standards.

Market Size & Forecast

2024 Market Size 102.5 (USD Million)
2035 Market Size 186.5 (USD Million)
CAGR (2025 - 2035) 5.59%

Major Players

Zoetis (IN), Merck Animal Health (IN), Boehringer Ingelheim (IN), Hester Biosciences (IN), Indian Immunologicals (IN), Venkateshwara Hatcheries (IN), Ceva Santé Animale (IN), Alltech (IN)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

India Poultry Vaccines Market Trends

The India Poultry Vaccines Market is currently experiencing a notable transformation, driven by the increasing demand for poultry products and the rising awareness of animal health. The government of India has been actively promoting vaccination programs to enhance poultry health and productivity. This initiative is crucial, as it aims to mitigate the impact of diseases that can significantly affect poultry populations. Furthermore, advancements in vaccine technology are contributing to the development of more effective and safer vaccines, which is likely to bolster the market's growth. The integration of innovative solutions, such as recombinant vaccines and adjuvants, appears to be gaining traction among poultry farmers, who are seeking to improve the overall health of their flocks. In addition to technological advancements, the regulatory framework surrounding poultry vaccines in India is evolving. The government is implementing stricter guidelines to ensure the quality and efficacy of vaccines available in the market. This regulatory oversight is expected to enhance consumer confidence and encourage the adoption of vaccination practices among poultry farmers. Moreover, the increasing focus on biosecurity measures and disease prevention strategies is likely to further drive the demand for vaccines in the India Poultry Vaccines Market. As the industry continues to adapt to changing consumer preferences and health standards, the future of poultry vaccination in India appears promising, with potential for sustained growth and innovation.

Technological Advancements in Vaccines

The India Poultry Vaccines Market is witnessing a shift towards advanced vaccine technologies. Innovations such as recombinant vaccines and vector-based vaccines are becoming more prevalent. These technologies offer enhanced efficacy and safety, addressing the specific health challenges faced by poultry in India. As farmers seek better solutions for disease management, the adoption of these advanced vaccines is likely to increase.

Regulatory Developments

The regulatory landscape for poultry vaccines in India is undergoing significant changes. The government is implementing stricter regulations to ensure the quality and safety of vaccines. This increased oversight is expected to enhance the credibility of vaccine products in the market. Consequently, poultry farmers may become more inclined to adopt vaccination practices, knowing that the vaccines meet stringent standards.

Rising Awareness of Animal Health

There is a growing awareness among poultry farmers in India regarding the importance of animal health and vaccination. Educational initiatives and outreach programs are helping to inform farmers about the benefits of vaccination in preventing diseases. This heightened awareness is likely to drive the demand for poultry vaccines, as farmers recognize the value of maintaining healthy flocks for improved productivity.

India Poultry Vaccines Market Drivers

Emerging Disease Threats

The emergence of new poultry diseases poses a significant challenge to the poultry industry in India, thereby driving the demand for vaccines. Recent outbreaks of avian influenza and Newcastle disease have highlighted the vulnerability of poultry flocks to infectious diseases. The India Poultry Vaccines Market is responding to these threats by developing and distributing vaccines that target these specific diseases. The increasing awareness of the potential economic losses associated with disease outbreaks is prompting poultry farmers to prioritize vaccination as a preventive measure. This heightened focus on disease management is likely to propel the growth of the India Poultry Vaccines Market, as farmers seek to protect their flocks and ensure sustainable production.

Increasing Poultry Production

The demand for poultry products in India is on the rise, driven by a growing population and changing dietary preferences. The India Poultry Vaccines Market is experiencing growth as poultry farmers seek to enhance production efficiency and ensure the health of their flocks. According to recent estimates, the poultry production in India is projected to reach approximately 10 million metric tons by 2026. This surge in production necessitates the use of effective vaccines to prevent diseases that can significantly impact yield. Consequently, the increasing poultry production is a key driver for the India Poultry Vaccines Market, as farmers invest in vaccines to safeguard their investments and meet the escalating demand for poultry products.

Government Initiatives and Support

The Indian government has implemented various initiatives to bolster the poultry sector, which in turn influences the India Poultry Vaccines Market. Programs aimed at enhancing biosecurity measures and promoting vaccination among poultry farmers are being prioritized. The government has also introduced subsidies for vaccine procurement, making them more accessible to small and medium-sized poultry operations. These initiatives are expected to increase vaccination rates, thereby reducing the incidence of poultry diseases. As a result, the supportive regulatory environment and financial assistance from the government are likely to drive growth in the India Poultry Vaccines Market, fostering a healthier poultry population and improving overall productivity.

Technological Innovations in Vaccine Development

Advancements in vaccine technology are playing a crucial role in shaping the India Poultry Vaccines Market. Innovations such as recombinant vaccines and vector-based vaccines are being developed to enhance efficacy and reduce the number of doses required. These technological improvements not only increase the effectiveness of vaccines but also streamline the vaccination process for poultry farmers. As a result, the adoption of these advanced vaccines is expected to rise, leading to improved flock health and productivity. The integration of technology in vaccine development is likely to be a driving force in the India Poultry Vaccines Market, as it aligns with the industry's need for efficient and effective disease control measures.

Growing Consumer Demand for Safe Poultry Products

There is a notable shift in consumer preferences towards safe and healthy poultry products in India. This trend is influencing the India Poultry Vaccines Market, as consumers increasingly demand assurance regarding the health and safety of poultry products. Farmers are responding to this demand by investing in vaccination programs to ensure their flocks are free from diseases. The emphasis on food safety and quality is prompting poultry producers to adopt comprehensive vaccination strategies, thereby driving the growth of the India Poultry Vaccines Market. As consumers continue to prioritize health-conscious choices, the pressure on poultry producers to maintain high standards of animal health will likely sustain the demand for effective vaccines.

Market Segment Insights

By Application: Infectious Bronchitis (Largest) vs. Newcastle Disease (Fastest-Growing)

In the India Poultry Vaccines Market, the application segment showcases a diverse landscape of vaccine types, with Infectious Bronchitis leading the market in share due to its widespread impact on poultry health. Following closely is Newcastle Disease, which is gaining traction as one of the fastest-growing segments, driven by increasing vaccination awareness and the rise of poultry farming practices across regions. Other notable applications include Avian Influenza, Marek's Disease, and Coryza, each contributing to the overall health management of poultry in the country.

Infectious Bronchitis: Dominant vs. Newcastle Disease: Emerging

Infectious Bronchitis remains the dominant force in the India Poultry Vaccines Market due to its severe economic impact on the poultry sector, with producers acknowledging its importance through consistent vaccination practices. On the other hand, Newcastle Disease, recognized for its threats to both poultry health and productivity, is emerging rapidly as farmers become more informed about vaccines' preventive measures. The rising demand for biosecurity and disease management is further establishing Newcastle Disease vaccinations as essential, signaling a transition in market dynamics where both applications will play critical roles in ensuring poultry welfare and production efficiency.

By Type: Live Attenuated Vaccines (Largest) vs. Recombinant Vaccines (Fastest-Growing)

In the India Poultry Vaccines Market, live attenuated vaccines hold the largest share of the segment, reflecting their widespread acceptance due to proven efficacy and long-lasting immunity in poultry populations. Meanwhile, recombinant vaccines are rapidly expanding, driven by advancements in genetic engineering that enhance their specificity and safety, appealing to a more health-conscious farming community. Growth trends within this segment indicate a notable shift towards innovative vaccine technologies. As poultry farming evolves with an increased focus on biosecurity and disease management, the demand for inactivated vaccines is also rising. Furthermore, the growing awareness of animal welfare and nutritional benefits is influencing farmers to adopt recombinant and DNA vaccines, leading to a dynamic market landscape.

Live Attenuated Vaccines (Dominant) vs. Inactivated Vaccines (Emerging)

Live attenuated vaccines are recognized as the dominant force within the Indian poultry vaccines market due to their long-standing success in immunizing against various poultry diseases. These vaccines effectively induce strong immune responses, enabling farmers to maintain the health and productivity of their flocks. Conversely, inactivated vaccines are emerging as a pivotal segment driven by their safety profile and effectiveness in disease prevention. These vaccines are increasingly being sought after, particularly in operations focused on organic or antibiotic-free farming practices. As the market continues to evolve, both vaccine types are expected to coexist, catering to the diverse needs of poultry producers in India.

By Route of Administration: Intramuscular (Largest) vs. Oral (Fastest-Growing)

The route of administration segment in the India Poultry Vaccines Market showcases a diverse landscape, with intramuscular administration holding the largest market share. This method is widely preferred for its efficacy and rapid absorption rate, making it the go-to choice for vaccination in poultry. Oral administration, while holding a smaller share, is rapidly gaining popularity due to its ease of application and logistical advantages, particularly in larger farming operations. The growth trends within this segment are influenced by several factors, including advancements in vaccine technology and the increased awareness of biosafety among poultry farmers. The shift towards oral vaccines is notable, as it often facilitates mass vaccination campaigns, ultimately driving the demand for this method. As farmers seek more efficient solutions, the oral route is positioned to expand significantly over the coming years.

Intramuscular (Dominant) vs. Subcutaneous (Emerging)

In the India Poultry Vaccines Market, the intramuscular route of administration is dominant due to its effectiveness in delivering vaccines directly into muscle tissues, resulting in robust immune responses. It is widely adopted among poultry producers for its reliability and established protocols. In contrast, the subcutaneous route is emerging, offering advantages such as reduced stress on birds and easier administration. This method is garnering attention as it may reduce the burden of handling and restraining the animals during vaccination, addressing animal welfare concerns. While intramuscular methods remain the standard, the subcutaneous approach is becoming more relevant as farmer preferences evolve towards more animal-friendly techniques.

By Target Species: Broilers (Largest) vs. Layers (Fastest-Growing)

The India Poultry Vaccines Market shows a clear segmentation by target species, with broilers holding the largest share due to their critical role in India's meat production. They are favored for their rapid growth and efficiency in conversion, propelling the demand for specialized vaccines to ensure their health and productivity. Layers, on the other hand, are emerging as the fastest-growing segment, driven by the escalating demand for egg production in urban areas. A surge in poultry farming practices has further accelerated this trend, leading to increased investment in vaccine development for layers. In terms of growth trends, the broiler segment benefits from advancements in veterinary medicine and vaccination techniques that enhance growth rates and overall flock health. Additionally, government initiatives support the poultry sector's development, promoting biosecurity and vaccination protocols. The layers segment, fueled by changing dietary preferences and rising awareness of health benefits, is witnessing an expansion in innovative vaccine solutions tailored to combat specific diseases. As consumer preferences evolve, this segment is on track for considerable growth, highlighting the importance of targeted vaccine strategies to achieve optimal production and safety.

Broilers (Dominant) vs. Layers (Emerging)

Broilers continue to dominate the India Poultry Vaccines Market due to their significant contribution to meat supply and the efficiency of production. With breeding practices aimed at achieving faster growth rates, broilers have a well-defined vaccination schedule to prevent diseases that can hinder growth and productivity. The market for broiler vaccines includes a range of products tailored to address common ailments, thus promoting better health and maximizing yield. Conversely, layers represent an emerging segment driven by the rising demand for eggs, as per capita consumption continues to grow. The focus for vaccines in this segment is primarily on preventing diseases that affect egg production and overall bird health, ensuring high-quality output. The shift towards improved biosecurity measures and innovative vaccination solutions is expected to play a critical role in the growth prospects for layer vaccines in the coming years.

Get more detailed insights about India Poultry Vaccines Market

Key Players and Competitive Insights

The Poultry Vaccines Market in India is characterized by a dynamic competitive landscape, driven by increasing demand for poultry products and a growing awareness of animal health. Key players such as Zoetis (IN), Merck Animal Health (IN), and Hester Biosciences (IN) are strategically positioned to leverage innovation and regional expansion to enhance their market presence. Zoetis (IN) focuses on developing advanced vaccine formulations, while Merck Animal Health (IN) emphasizes partnerships with local distributors to optimize supply chains. Hester Biosciences (IN) is actively investing in research and development to introduce novel vaccines, which collectively shapes a competitive environment that is increasingly focused on technological advancements and customer-centric solutions.

The market structure appears moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and enhance supply chain efficiency. This strategy not only mitigates risks associated with global supply chain disruptions but also allows companies to respond swiftly to regional demands. The collective influence of these key players fosters a competitive atmosphere where innovation and operational efficiency are paramount.

In December 2025, Zoetis (IN) announced the launch of a new vaccine targeting avian influenza, which is expected to significantly enhance poultry health and productivity. This strategic move underscores the company's commitment to addressing emerging health challenges in the poultry sector. By introducing this vaccine, Zoetis (IN) aims to solidify its market leadership and respond to the increasing prevalence of avian diseases, thereby reinforcing its competitive edge.

In November 2025, Merck Animal Health (IN) expanded its distribution network through a partnership with local veterinary clinics across India. This initiative is likely to enhance accessibility to their vaccine products, thereby increasing market penetration. The strategic importance of this partnership lies in its potential to improve customer engagement and foster trust within the local farming communities, which is crucial for long-term growth.

In October 2025, Hester Biosciences (IN) secured a collaboration with a leading agricultural university to develop next-generation vaccines. This partnership is indicative of a broader trend towards academia-industry collaboration, which may accelerate innovation in vaccine development. By leveraging academic research, Hester Biosciences (IN) could enhance its product offerings and maintain a competitive advantage in a rapidly evolving market.

As of January 2026, current trends in the Poultry Vaccines Market indicate a shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise. The evolution of competitive differentiation appears to be moving away from price-based competition towards a focus on innovation, technology, and supply chain reliability. This transition suggests that companies that prioritize research and development, alongside sustainable practices, are likely to thrive in the future.

Key Companies in the India Poultry Vaccines Market include

Industry Developments

The India Poultry Vaccines Market has seen significant developments recently, particularly in the launch of innovative vaccines and expansions by key players. Notably, in September 2023, Hester Biosciences introduced a new vaccine against a prevalent avian disease, improving the health of poultry and meeting rising demand in the region.

Indian Immunologicals has also been active, announcing plans to increase its production capacity for poultry vaccines to cater to the growing market. In terms of mergers and acquisitions, in August 2023, Boehringer Ingelheim announced its acquisition of a local vaccine development firm, strengthening its position in the Indian market.

The market is experiencing healthy growth, driven by rising poultry consumption and increasing awareness of animal health, with estimates projecting a compound annual growth rate of over 10% from 2022 to 2027. Additionally, the ongoing impact of the government's initiatives to enhance biosecurity measures in poultry farming is expected to create new opportunities for vaccine manufacturers. The collective efforts of these companies including Zoetis, Ceva Santé Animale, Merck Animal Health, and others contribute to a dynamic landscape, shaping the future of poultry health in India.

Future Outlook

India Poultry Vaccines Market Future Outlook

The India Poultry Vaccines Market is projected to grow at a 5.59% CAGR from 2025 to 2035, driven by increasing poultry production and rising disease outbreaks.

New opportunities lie in:

  • Development of customized vaccine formulations for regional poultry diseases.
  • Expansion of digital platforms for vaccine tracking and management.
  • Investment in advanced cold chain logistics for vaccine distribution.

By 2035, the market is expected to be robust, driven by innovation and strategic investments.

Market Segmentation

India Poultry Vaccines Market Type Outlook

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • DNA Vaccines

India Poultry Vaccines Market Application Outlook

  • Infectious Bronchitis
  • Newcastle Disease
  • Avian Influenza
  • Marek's Disease
  • Coryza

India Poultry Vaccines Market Target Species Outlook

  • Broilers
  • Layers
  • Breeders
  • Turkeys

India Poultry Vaccines Market Route of Administration Outlook

  • Intramuscular
  • Subcutaneous
  • Oral
  • Intraocular

Report Scope

MARKET SIZE 2024102.5(USD Million)
MARKET SIZE 2025108.85(USD Million)
MARKET SIZE 2035186.5(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)5.59% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies ProfiledZoetis (IN), Merck Animal Health (IN), Boehringer Ingelheim (IN), Hester Biosciences (IN), Indian Immunologicals (IN), Venkateshwara Hatcheries (IN), Ceva Santé Animale (IN), Alltech (IN)
Segments CoveredApplication, Type, Route of Administration, Target Species
Key Market OpportunitiesIncreasing demand for innovative vaccines due to rising poultry health awareness in India.
Key Market DynamicsRising demand for poultry vaccines in India driven by regulatory changes and increasing awareness of animal health.
Countries CoveredIndia
Leave a Comment

FAQs

What is the current valuation of the India Poultry Vaccines Market?

The India Poultry Vaccines Market was valued at 102.5 USD Million in 2024.

What is the projected market valuation for the India Poultry Vaccines Market by 2035?

The projected valuation for the India Poultry Vaccines Market is 186.5 USD Million by 2035.

What is the expected CAGR for the India Poultry Vaccines Market during the forecast period?

The expected CAGR for the India Poultry Vaccines Market from 2025 to 2035 is 5.59%.

Which companies are the key players in the India Poultry Vaccines Market?

Key players in the market include Zoetis, Merck Animal Health, Boehringer Ingelheim, Hester Biosciences, Indian Immunologicals, Venkateshwara Hatcheries, Ceva Santé Animale, and Alltech.

What are the main applications of poultry vaccines in the Indian market?

The main applications include Infectious Bronchitis, Newcastle Disease, Avian Influenza, Marek's Disease, and Coryza.

How much revenue did the Infectious Bronchitis segment generate in 2024?

The Infectious Bronchitis segment generated revenue between 25.0 and 45.0 USD Million in 2024.

What types of vaccines are prevalent in the India Poultry Vaccines Market?

The prevalent types of vaccines include Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, and DNA Vaccines.

What is the revenue range for Live Attenuated Vaccines in 2024?

Live Attenuated Vaccines generated revenue between 30.0 and 55.0 USD Million in 2024.

Which target species contribute most to the market revenue?

Broilers, Layers, Breeders, and Turkeys are the primary target species contributing to market revenue.

What was the revenue range for the Broilers segment in 2024?

The Broilers segment generated revenue between 40.0 and 75.0 USD Million in 2024.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions